THC

United States Intoxicating Hemp Products Market Report 2021: Opportunity or Risk? - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 19, 2022
Tobacco, Retail, Risk, US Foods, Drug, THCP, Drug Enforcement Agency, United States farm bill, Food, THC, FDA, HHC, 2018 United States farm bill, 2020 Indian agriculture acts, DEA

The "Intoxicating Hemp Products in the US - Opportunity or Risk?"

Key Points: 
  • The "Intoxicating Hemp Products in the US - Opportunity or Risk?"
  • Despite the intent of the 2018 US Farm Bill to restrict intoxicating substances made from hemp, some companies are selling intoxicating cannabinoid products and claiming legality under the Farm Bill.
  • However THCP, an intoxicating cannabinoid discovered in 2019, is too novel to fully establish its legal status.
  • The US Food and Drug Administration (FDA) and potentially the Drug Enforcement Agency (DEA), could bring enforcement action against producers of some of these intoxicating products if they so choose.

ACS Laboratory Announces New THCOa Safety Bundle

Retrieved on: 
Wednesday, January 19, 2022
Emerald, Technology, BOCA, Cannabis, CLIA, Safety, Florida Department of Agriculture and Consumer Services, DEA, Cannabinoid, Industry, THC, Attention, Florida Department, Compliance, ACS, USDA, Blog, Drug, Pharmaceutical industry

BOCA RATON, Fla., Jan. 19, 2022 /PRNewswire/ -- Raising the standard for cannabis and hemp testing, ACS Laboratory , the largest hemp and cannabis testing facility in the eastern U.S., has developed the THCOa Safety Bundle Test, a testing panel to test for THC-O Acetate (THCOa), acetic anhydride and other specific cannabinoids.

Key Points: 
  • BOCA RATON, Fla., Jan. 19, 2022 /PRNewswire/ -- Raising the standard for cannabis and hemp testing, ACS Laboratory , the largest hemp and cannabis testing facility in the eastern U.S., has developed the THCOa Safety Bundle Test, a testing panel to test for THC-O Acetate (THCOa), acetic anhydride and other specific cannabinoids.
  • With the THCOa Safety Bundle, ACS Laboratory, a DEA-licensed laboratory, now tests for a total of 22 cannabinoids, more than any other cannabis or hemp lab in the U.S.
  • "When creating our THCOa Safety Bundle, we not only took the time to create a method for THCOa, but also a method for the potential harmful chemical, acetic anhydride, that is used as a reactor to ensure safety and purity for the consumer and for ACS Laboratory to continue to be a good corporate citizen," said Roger Brown, president of ACS Laboratory.
  • An ISO 17025 accredited, DEA licensed, and CLIA licensed accredited laboratory, ACS Laboratory offers the largest state-of-the-art testing facility in cannabis and hemp testing in the eastern U.S.

Open Book Extracts Expands Business Development and Regulatory Team to Support European Growth and Distribution Efforts

Retrieved on: 
Wednesday, January 19, 2022
Aurora, Home, Association, IP, Shikimate pathway, Warwick Business School, Technology, European Industrial Hemp Association, CBG, EIHA, Research Triangle, Hut Group, MHRA, CBT, Supply, Home Office, Tetrahydrocannabivarin, UKAS, Tablet, Cannabidivarin, FDF, CBN, MBA, FSA, CBD, Drink, Growth, CBC, Cannabinoid, THC, OBX, Industry, Method, FSAI, Food, Doctor of Philosophy, Capsule, HPRA, Cosmetics, THG, The Hut Group, Reeves, United Kingdom, Supply chain, Dietary supplement, EU, Hemp, Telecommunication

In November 2021, OBX announced the establishment of OBX Europe , with local leadership from Najeeb Qazizada, Director of Supply Chain for OBX Europe.

Key Points: 
  • In November 2021, OBX announced the establishment of OBX Europe , with local leadership from Najeeb Qazizada, Director of Supply Chain for OBX Europe.
  • In previous roles, Reeves was a consultant to Pyxus International/FIGR Brands Europe and European Managing Director for Aurora Hemp, and he holds an MBA from Warwick Business School.
  • Headquartered in Roxboro, N.C., Open Book Extracts is a cGMP-certified manufacturer of premium plant-based cannabinoid products, aiming to be the industry's true north by delivering premium products, exceptional service, and industry-leading transparency.
  • OBX Asia, with its headquarters in Hong Kong, provides strategic guidance and on-the-ground support for our Asia customers.

Feds Loosen Grip on Cannabis

Retrieved on: 
Tuesday, January 18, 2022
Emerald, Light, Drug Enforcement Administration, PH, PTSD, Research, Technology, News, PAR, Opioid, Drug, Sleep apnea, Biological response modifier, Good manufacturing practice, CBD, Cannabis, Growth, Humidity, Soil, CEO, Chronic pain, DEA, Automation, Veteran, Temperature, Interview, Wireless, HVAC, Health, API, Communication, THC, Government, Law enforcement, Anxiety, United States Department of Veterans Affairs, Edward Hines Jr. Veterans Administration Hospital, CO2, Depression, CGMP, Multimedia, Horticulture, Food, Federation, FDA, REP, Food and Drug Administration, Active ingredient, LED, University, Pharmaceutical industry, Dietary supplement

REP is the first-of-its-kind cannabis pharmaceutical company in the United States to receive these highly coveted licenses.

Key Points: 
  • REP is the first-of-its-kind cannabis pharmaceutical company in the United States to receive these highly coveted licenses.
  • This latest move by the DEA is a clear message that the federal government is loosening its grip on marijuana specifically grown for research purposes.
  • It has been a long and hard battle for entrepreneurs in the cannabis industry to win approval from the DEA, but now it has finally happened.
  • "We are excited and very happy to receive these DEA licenses for cannabis research," said Mark Crozier, Founder and CEO of Royal Emerald Pharmaceuticals.

Trulieve and Connected Cannabis Expand Partnership to Florida

Retrieved on: 
Tuesday, January 18, 2022
Breeding, Patient, Connected, Cannabis, CBD, Growth, CEO, OTCQX, Industry, THC, Company, Genetics, CSE, Partnership, Drug

TALLAHASSEE, Fla., Jan. 18, 2022 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced an expanded partnership with Connected Cannabis Co. ("Connected"), a premier cannabis cultivator.

Key Points: 
  • TALLAHASSEE, Fla., Jan. 18, 2022 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced an expanded partnership with Connected Cannabis Co. ("Connected"), a premier cannabis cultivator.
  • "Trulieve is excited about expanding our partnership with Connected as we continue seeking ways to benefit our patients," said Kim Rivers, CEO of Trulieve.
  • "We're proud to expand our successful partnership with Trulieve to bring our award-winning Connected and Alien Labs products to the East Coast," said Caleb Counts, co-founder of Connected.
  • Connected Cannabis Co. has been breeding, growing and selling the best cannabis in the world since 2009 through its Connected and Alien Labs brands.

Hometown Hero CBD Announces Product With CBDA and CBGA Is Underway

Retrieved on: 
Friday, January 14, 2022
PR, CBD, CBGA, Organic, Edible, Instagram, Veteran, CBDA, United States Coast Guard, THC, Facebook, Industry, Twitter, Sunlight, Organization, Food delivery

AUSTIN, Texas, Jan. 14, 2022 /PRNewswire/ --Hometown Hero CBD, announces today that it is developing an edible with CBDA and CBGA as its primary cannabinoids.

Key Points: 
  • AUSTIN, Texas, Jan. 14, 2022 /PRNewswire/ --Hometown Hero CBD, announces today that it is developing an edible with CBDA and CBGA as its primary cannabinoids.
  • Recently, Hometown Hero CBD launched its Hybrid Live Rosin Gummies, the first product of its kind in the consumable hemp market.
  • As with all of its products, Hometown Hero CBD plans to donate a portion of proceeds from its CBDA and CBGA edibles to nonprofit organizations that help veterans in need.
  • "We're very excited to announce this upcoming CBDA and CBGA product," said Lewis Hamer, Vice President of Hometown Hero CBD.

Tenet to Report its Fourth Quarter 2021 Results on February 7

Retrieved on: 
Friday, January 14, 2022
Health, Hospitals, Surgery, Practice Management, Other Health, Managed Care, General Health, Central, Ownership, Tenet Healthcare, United Surgical Partners International, NYSE, THC, Hospital, Medicine

Tenet Healthcare Corporation (NYSE: THC) plans to report results for its fourth quarter ended December 31, 2021 after the market closes on Monday, February 7, 2022.

Key Points: 
  • Tenet Healthcare Corporation (NYSE: THC) plans to report results for its fourth quarter ended December 31, 2021 after the market closes on Monday, February 7, 2022.
  • The company will host a related conference call the following morning, Tuesday, February 8, 2022, at 10:00 a.m. Eastern time (9:00 a.m. Central time).
  • Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas.
  • Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve.

Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical Pioneer Knop Laboratorios S.A.

Retrieved on: 
Friday, January 14, 2022
Aureus, Research, LinkedIn, Perception, MaRS Discovery District, Wellness, Dermatology, Trial of the century, Chronic pain, Knop, National Organ Transplant Act of 1984, Seed, TSX, Lists of diseases, API, Cannabidiol, Risk, Social media, National Organic Program, Bulk, Instagram, Cannabinoid, Company, United States Department of Agriculture, Fair Debt Collection Practices Act, Partnership, SEDAR, FSE, News, RHO, Absorption, Solution, THC, Facebook, GLOBE, GMP, Herbal medicine, Twitter, Prospectus, Fine chemical, Pharmaceutical industry, CBD

TORONTO, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that through its majority owned subsidiary Santa Marta Golden Hemp (“SMGH”) the company has entered into a Master Supply Agreement with established Chilean pharmaceutical company Knop Laboratorios S.A. (“Knop”) to supply a range of cannabinoid-based active pharmaceutical ingredients (“API”) for the manufacturing, and commercialization of proprietary cannabinoid-based pharmaceutical products in Latin America.

Key Points: 
  • Knop Laboratorios S.A. is a Chilean pharmaceutical company and pioneer in herbal medicine with more than 90 years of experience in the field and active presence in several Latin American countries including Chile, Ecuador, Colombia, Bolivia, Paraguay, and Peru.
  • With a GMP certified plant located in Quilpu, Chile, Knop Laboratorios serves its markets with high-quality pharmaceutical products.
  • In 2021, Knop opened the first R&D Center in Chile for phytomedicines and active ingredients of natural origin.
  • Knop is carrying out various Clinical Studies for their cannabinoid-based products, with authorization from the appropriate health authorities.

The Flowr Corporation Announces International Commercialization of Its Flagship Strains – BC Black Cherry and BC Strawnana

Retrieved on: 
Thursday, January 13, 2022
Patient, LinkedIn, Union, KIND, Cannabis, Pharmacy, Growth, NASDAQ, GLOBE, Quality control, GMP, OTC, THC, Ecosystem, Company, CSE, Twitter, Project, Partnership, Drug, IMC, BC

TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- The Flowr Corporation (“Flowr” or the “Company”) (TSXV: FLWR, OTC: FLWPF) is pleased to announce that it has completed its first shipment from Canada to Israel, as part of the previously announced international supply agreement (the “Supply Agreement”) with Focus Medical Herbs Ltd. (“Focus Medical”), a company which IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) (“IMC”) has an exclusive commercial agreement with in Israel.

Key Points: 
  • The first shipment consisted of premium cannabis across two strains for a total of $825,000.
  • The shipment represents the Companys debut into the Israeli market and the first significant international export.
  • Holigen is in the final stages of cultivating BC Black Cherry and BC Strawnana strains and expects to commence harvesting at its purpose-built indoor facility in Sintra, Portugal by the end of January 2022.
  • For more information, please visit flowrcorp.com or follow Flowr on Twitter: @FlowrCanada and LinkedIn: The Flowr Corporation.

Boston Hemp: Hemp Study Shows Benefits Protecting Against Covid-19

Retrieved on: 
Thursday, January 13, 2022
Oregon State University, Journal of Natural Products, Natural product, Research, Hemp, News, Human, CBG, Journal, COVID-19, CBN, Severe acute respiratory syndrome coronavirus 2, OSU, CBD, CBGA, CBDV, CBC, Dietary supplement, Cannabinoid, CBDA, THC, Industry, Food, Multimedia, Cosmetics, Infection, CBNA, Coronavirus, University

BOSTON, Jan. 13, 2022 /PRNewswire/ -- A new study in the hemp and cannabis industry has demonstrated amazing results on behalf of the hemp plant, regarding COVID-19.

Key Points: 
  • BOSTON, Jan. 13, 2022 /PRNewswire/ -- A new study in the hemp and cannabis industry has demonstrated amazing results on behalf of the hemp plant, regarding COVID-19.
  • In this study, the hemp cannabinoids bound to spike proteins found on the virus and immediately blocked the pathogen commonly found to infect humans.
  • These included CBNA, CBG, CBN, Delta-8 THC, CBD, CBC, and CBDV, all which are contained within the hemp flower from Boston Hemp.
  • Hemp has been used for centuries as a source of fiber and food, but is now being used in lotions, cosmetics and dietary supplements by companies like Boston Hemp Inc.